(Q44255331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

main subject

opportunistic infection

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Elena Losina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

6

M C Weinstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

12

K A Freedberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

Y Yazdanpanah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

8

A D Kimmel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

S J Goldie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

L Coudeville

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Y Gerard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

H Zhang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

R Salamon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Y Mouton

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

11 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

86-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

AIDS across Europe, 1994-98: the EuroSIDA study

16 December 2019

cites work

1 reference

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines

21 January 2018

1 reference

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

21 January 2018

1 reference

The cost-effectiveness of preventing AIDS-related opportunistic infections

21 January 2018

1 reference

HIV-associated brain pathology: a comparative international study.

21 January 2018

1 reference

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

21 January 2018

1 reference

The cost effectiveness of combination antiretroviral therapy for HIV disease.

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts

21 January 2018

1 reference

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

21 January 2018

1 reference

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

21 January 2018

1 reference

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

21 January 2018

1 reference

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study

21 January 2018

1 reference

Assessing the cost-effectiveness of HAART for adults with HIV in England

21 January 2018

1 reference

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

21 January 2018

1 reference

Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study.

21 January 2018

1 reference

Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis.

21 January 2018

1 reference

Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis

21 January 2018

1 reference

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

21 January 2018

1 reference

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

21 January 2018

1 reference

Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus

21 January 2018

1 reference

Effect of an Explicit Decision-Support Tool on Decisions to Prescribe Antibiotics for Sore Throat

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/344902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12491207%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference